From: Influence of diabetes on short-term outcome after major hepatectomy: an underestimated risk?
 | Study population | Normal weight | Overweight | Obesity | ||
---|---|---|---|---|---|---|
 | n/N (%) or mean ± standard deviation | n (%) | n (%) | p†| n (%) | p†|
Total | 417/417 (100) | 204 (49.3) | 147 (35.5) | Â | 48 (11.6) | Â |
Pre-operative patient characteristics | Â | Â | Â | Â | ||
Diabetes mellitus | 59/417 (14.1) | 22 (10.8) | 27 (18.4) | 0.06 | 7 (14.6) | 0.62 |
Age (years), n = 417 | 59.1 ± 13.4 |  |  |  |  |  |
 Age ≥ 60 years | 226/417 (54.2) | 105 (51.5) | 90 (61.2) | 0.09 | 23 (47.9) | 0.78 |
Male gender | 232/417 (55.6) | 108 (52.9) | 95 (64.6) | 0.04 | 26 (54.2) | 1 |
ASA classification, n = 410 | 2.4 ± 0.6 |  |  |  |  |  |
 ASA III classification or more | 192/410 (46.8) | 84 (41.8) | 72 (50.3) | 0.14 | 27 (56.3) | 0.1 |
Pre-existing disease | Â | Â | Â | Â | Â | |
 Arterial hypertension | 184/417 (44.1) | 67 (32.8) | 78 (53.1) | 0.0002 | 33 (68.8) |  < 0.0001 |
 Cardiac failure | 7/417 (1.7) | 1 (0.5) | 2 (1.4) | 0.57 | 4 (8.3) | 0.01 |
 Chronic renal failure | 16/417 (3.8) | 4 (2) | 9 (6.1) | 0.08 | 2 (4.2) | 0.32 |
 Lung disease | 33/417 (7.9) | 13 (6.4) | 12 (8.2) | 0.66 | 4 (8.3) | 0.54 |
 Hepatitis B or C | 18/417 (4.3) | 8 (3.9) | 6 (4.1) | 1 | 3 (6.3) | 0.44 |
 Esophageal varices | 4/417 (1) | 3 (1.5) | 1 (0.7) | 0.64 | 0 (0) | 1 |
Regular alcohol consumption | 28/417 (6.7) | 11 (5.4) | 10 (6.8) | 0.75 | 5 (10.4) | 0.2 |
Nicotine abuse | 69/417 (16.5) | 30 (14.7) | 25 (17) | 0.66 | 6 (12.5) | 0.87 |
Pre-operative treatment | Â | Â | Â | Â | Â | |
 Chemotherapy | 106/417 (25.4) | 52 (25.5) | 36 (24.5) | 0.93 | 11 (22.9) | 0.85 |
 Chemoembolization | 11/417 (2.6) | 7 (3.4) | 3 (2) | 0.53 | 1 (2.1) | 1 |
 Portal vein embolization | 12/417 (2.9) | 10 (4.9) | 2 (1.4) | 0.13 | 0 (0) | 0.22 |
Laboratory values | Â | Â | Â | Â | Â | Â |
 INR > 1.2 | 11/416 (2.6) | 7 (3.4) | 3 (2) | 0.53 | 0 (0) | 0.35 |
 Total bilirubin > 1 mg/dl | 80/411 (19.5) | 43 (21.3) | 28 (19.3) | 0.75 | 6 (12.8) | 0.26 |
Characteristics of surgery | Â | Â | Â | Â | Â | |
Extent of surgery | Â | Â | Â | Â | Â | Â |
 Right hemihepatectomy | 226/417 (54.2) | 110 (53.9) | 77 (52.4) | 0.86 | 25 (52.1) | 0.95 |
 Left hemihepatectomy | 90/417 (21.6) | 43 (21.1) | 34 (23.1) | 0.74 | 12 (25) | 0.69 |
 Right trisectionectomy | 56/417 (13.4) | 31 (15.2) | 17 (11.6) | 0.41 | 6 (12.5) | 0.8 |
 Left trisectionectomy | 27/417 (6.5) | 13 (6.4) | 10 (6.8) | 1 | 4 (8.3) | 0.54 |
 Segment resection* | 18/417 (4.3) | 7 (3.4) | 9 (6.1) | 0.35 | 1 (2.1) | 1 |
Adrenalectomy | Â | 5 (2.5) | 3 (2) | 1 | 4 (8.3) | 0.07 |
Biliodigestive anastomosis | Â | 55 (27) | 41 (27.9) | 0.94 | 8 (16.7) | 0.19 |
Resection device / technique | Â | Â | Â | Â | Â | Â |
 Stapler |  | 142 (72.1) | 108 (74.5) | 0.71 | 35 (76.1) | 0.71 |
 Ligasure |  | 20 (10.2) | 10 (6.9) | 0.39 | 2 (4.3) | 0.27 |
 Clamp-crushing technique |  | 14 (7.1) | 15 (10.3) | 0.39 | 6 (13) | 0.23 |
 CUSA |  | 17 (8.6) | 10 (6.9) | 0.71 | 3 (6.5) | 0.77 |
 Others |  | 4 (2) | 2 (1.4) | 1 | 0 (0) | 1 |
Pringle maneuver | Â | 41 (20.5) | 30 (20.5) | 1 | 11 (23.4) | 0.81 |
Operative time (min), n = 410 |  |  |  |  |  |  |
Blood loss ≥ 1000 ml, n = 409 |  | 74 (37) | 59 (41.3) | 0.49 | 11 (22.9) | 0.09 |
Transfusion of pRBC | Â | 70 (34.3) | 57 (38.8) | 0.46 | 15 (31.3) | 0.81 |
Characteristics of histopathology | Â | Â | Â | Â | Â | |
Non-malignant indication |  | 27 (13.2) | 19 (12.9) | – | 5 (10.4) | – |
 Living liver donation |  | 5 (2.5) | 3 (2) | 1 | 0 (0) | 0.59 |
Malignant indication | Â | 177 (86.8) | 128 (87.1) | 1 | 43 (89.6) | 0.77 |
 Colorectal liver metastasis |  | 53 (26) | 46 (31.3) | 0.33 | 18 (37.5) | 0.16 |
 Other liver metastases |  | 33 (16.2) | 18 (12.2) | 0.38 | 3 (6.3) | 0.12 |
 Cholangiocarcinoma |  | 65 (31.9) | 51 (34.7) | 0.66 | 18 (37.5) | 0.56 |
 Hepatocellular carcinoma |  | 22 (10.8) | 10 (6.8) | 0.28 | 3 (6.3) | 0.43 |
 Other malignant tumor |  | 4 (2) | 3 (2) | 1 | 1 (2.1) | 1 |
Tumor diameter > 2.5 cm |  | 129 (71.7) | 92 (71.3) | 1 | 37 (78.7) | 0.43 |
Liver cirrhosis | Â | 8 (3.9) | 4 (2.7) | 0.75 | 3 (6.3) | 0.44 |
Liver steatosis ≥ 5% |  | 55 (27) | 62 (42.2) | 0.004 | 35 (72.9) |  < 0.0001 |